ESSA Pharma Inc (EPIX)
1.825
+0.06
(+3.69%)
USD |
NASDAQ |
Nov 22, 13:01
ESSA Pharma Enterprise Value: -52.60M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -52.60M |
| November 20, 2024 | -53.94M |
| November 19, 2024 | -53.49M |
| November 18, 2024 | -54.82M |
| November 15, 2024 | -54.38M |
| November 14, 2024 | -52.60M |
| November 13, 2024 | -52.16M |
| November 12, 2024 | -48.17M |
| November 11, 2024 | -51.27M |
| November 08, 2024 | -50.83M |
| November 07, 2024 | -52.16M |
| November 06, 2024 | -54.82M |
| November 05, 2024 | -55.27M |
| November 04, 2024 | -58.37M |
| November 01, 2024 | -68.58M |
| October 31, 2024 | 100.02M |
| October 30, 2024 | 103.57M |
| October 29, 2024 | 109.34M |
| October 28, 2024 | 112.89M |
| October 25, 2024 | 115.55M |
| October 24, 2024 | 134.19M |
| October 23, 2024 | 107.57M |
| October 22, 2024 | 123.98M |
| October 21, 2024 | 136.41M |
| October 18, 2024 | 139.07M |
| Date | Value |
|---|---|
| October 17, 2024 | 125.31M |
| October 16, 2024 | 140.84M |
| October 15, 2024 | 133.30M |
| October 14, 2024 | 136.41M |
| October 11, 2024 | 145.72M |
| October 10, 2024 | 122.21M |
| October 09, 2024 | 132.86M |
| October 08, 2024 | 126.20M |
| October 07, 2024 | 142.17M |
| October 04, 2024 | 137.29M |
| October 03, 2024 | 137.74M |
| October 02, 2024 | 138.18M |
| October 01, 2024 | 127.09M |
| September 30, 2024 | 138.18M |
| September 27, 2024 | 155.04M |
| September 26, 2024 | 144.84M |
| September 25, 2024 | 139.51M |
| September 24, 2024 | 142.62M |
| September 23, 2024 | 154.60M |
| September 20, 2024 | 155.93M |
| September 19, 2024 | 156.82M |
| September 18, 2024 | 137.74M |
| September 17, 2024 | 169.68M |
| September 16, 2024 | 179.89M |
| September 13, 2024 | 173.23M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-101.13M
Minimum
Oct 11 2022
1.187B
Maximum
Mar 12 2021
181.30M
Average
96.69M
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 906.94M |
| Edesa Biotech Inc | 4.811M |
| Lexaria Bioscience Corp | 25.27M |
| Xenon Pharmaceuticals Inc | 2.380B |
| ImmunoPrecise Antibodies Ltd | 8.777M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.234M |
| Total Expenses (Quarterly) | 8.884M |
| EPS Diluted (Quarterly) | -0.16 |
| Earnings Yield | -33.97% |